Kalium bichromicum 30c homeopathic tablets

Background: Chronic insomnia is a prevalent yet underdiagnosed condition affecting quality of life. Conventional treatments have limitations, highlighting the need for safe, individualised approaches. Homoeopathy, emphasising totality-based prescribing, offers an integrative solution, but comparative research on standardised versus individualised homoeopathic interventions is limited. Objectives: The study compares the clinical efficacy of individualised homoeopathic treatment (IHT) and Kalium Phosphoricum in managing chronic insomnia. Methods: A randomised, single-blind clinical trial was conducted on 30 patients diagnosed with chronic insomnia (ICSD-III and DSM-5 criteria) at a homoeopathic medical institution. Participants were randomised into two groups: one receiving Kalium Phosphoricum and the other receiving individualised remedies based on constitutional analysis. Outcomes were assessed using the Insomnia Severity Index (ISI). Results: Both groups showed significant improvement in ISI scores, with the IHT group showing a greater reduction (21.4 points) compared to the Kalium Phosphoricum group (8.67 points). Conclusion: The study found that personalised homoeopathic treatment, which differs from Kalium Phosphoricum, is more effective in managing chronic insomnia, thereby suggesting the potential benefit of individualised prescribing; however, findings are preliminary, limited by a small sample, subjective outcomes, and lack of placebo control.

Abstract licence: CC BY-NC-SA 4.0